首页> 外文OA文献 >The midlands trial of empirical amiodarone versus electrophysiology-guided interventions and implantable cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death

【2h】

The midlands trial of empirical amiodarone versus electrophysiology-guided interventions and implantable cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death

机译：胺碘酮与电生理学指导的干预措施和植入式心脏除颤器（MAVERIC）的中部试验：关于二级预防心源性猝死的多中心前瞻性随机临床试验

页面导航

摘要
著录项
相似文献
相关主题

摘要

21536

机译：21536

著录项

作者
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献

1. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients The Prospective, Randomized, Controlled ICD2 Trial [J] . Jukema J. Wouter, Timal Rohit J., Rotmans Joris I, Circulation: An Official Journal of the American Heart Association . 2019,第23期

机译：预防性使用植入式心脏除颤器在预防透析患者突然心脏死亡中的前瞻性，随机，控制的ICD2试验
2. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. [J] . Paul A Friedman, David Bradley, Celeste Koestler, Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . 2014,第10期

机译：单腔或双腔植入式心脏复律除颤器的一项前瞻性随机试验，旨在最大程度地降低预防原发性心脏猝死的不适当电击风险。
3. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. [J] . Packer DL, Prutkin JM, Hellkamp A Circulation: An Official Journal of the American Heart Association . 2009,第22期

机译：植入式心脏复律除颤器，胺碘酮和安慰剂对稳定的心力衰竭患者死亡模式的影响：心力衰竭试验中猝死的分析。
4. Latest Data From Secondary Prevention Implantable Cardioverter-Defibrillator Trials [C] . G. Naccarelli, O. Oseroff World Congress on Cardiac Pacing and Electrophysiology . 2003

机译：来自二级预防植入式心脏病 - 除颤器试验的最新数据
5. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data [O] . R Pathmanathan, E Lau, J Cooper, 1998

机译：抗心律不齐药物与植入式除纤颤器对室性心律失常的潜在影响：经验性胺碘酮与电生理指导干预和心脏复律植入物注册数据的Midlands试验
6. Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial” [O] . Douglas L. Packer, Robert P. Frantz, Jordan M. Prutkin, 2010

机译：对文章的回应，“植入心脏病 - 除颤器，胺碘酮和安慰剂对心力衰竭稳定患者死亡方式的影响：心力衰竭试验中突发的心脏死亡分析”

The midlands trial of empirical amiodarone versus electrophysiology-guided interventions and implantable cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death

摘要

著录项

相似文献

相关主题

期刊订阅